诺和诺德新任CEO首次亮相:专注糖尿病和减重、拥抱消费者市场、准备大并购|JPM26

Minhua笔记
Jan 14

1月13日,在J.P. Morgan医疗保健大会上,诺和诺德新任首席执行官Mike Doustdar用一场坦诚务实的演讲回应了投资者对公司2025年表现的普遍质疑。他承认过去几年“有很多本可以做得更好的地方”,并将2025年定义为“关键反思年”——公司从“领先者”转为“必须加速竞争者”。就任诺和诺德新任首席执行官五个月以来,Mike Doustdar 承受着巨大压力,需扭转这家被众多投资者视为...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10